Are there any reviews of KX-826 yet?
    Treatment 11/18/2024

    At a glance
    In this question or advice post, the primary subjects mentioned are
    ๐Ÿ’ง Pyrilutamide (KX-826) (topical) 1% 3 months
    the tone is ๐Ÿ˜ neutral with no regrowth results.

    Other terms

    Pyrilutamide (KX-826) is being discussed as a potential hair loss treatment, with some users reporting no regrowth after three months. It may prevent further hair loss but might not promote regrowth unless combined with Minoxidil.
    View this post in the Community โ†’

    Similar Community Posts Join

    6 / 759 results

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  117 upvotes 2 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

      community Pyrilutamide Phase 3 on its way

      in Treatment  128 upvotes 3 years ago
      Pyrilutamide Phase 3 approved, starting early 2022 with 416 subjects for 24 weeks. Drug potentially better than RU and Breezula, with some users reporting no side effects.

      community Fuck it, Iโ€™m ordering Pyri Topical

      in Product  13 upvotes 4 months ago
      A user plans to order Pyrilutamide for hair loss after losing ground on finasteride. Another user advises against buying from Hairliciously, suggesting Amazon instead.

      community Using Topical Minoxidil And Pyrilutamide Together

      in Treatment  1 upvotes 3 months ago
      Mixing 1ml of topical Minoxidil and Pyrilutamide (2ml total) together in a container and applying immediately is being discussed. The concern is whether this method degrades or compromises the efficacy of either compound.

      community What ever happened to pyrilutamide?

      in Technology  48 upvotes 1 year ago
      Pyrilutamide, a potentially effective hair loss treatment; other topical treatments like RU58841 and CB-03-01 that may have fewer side effects than Pyrilutamide; and the Phase 3 clinical trials of Pyrilutamide, which is likely to be approved by the FDA soon.

    Related Research

    6 / 8 results